Impact of Bone Marrow Pathology on the Clinical Management of Philadelphia Chromosome–Negative Myeloproliferative Neoplasms  Olga Pozdnyakova, Robert.

Slides:



Advertisements
Similar presentations
APMG Pathologist, MD FCAP
Advertisements

MLAB Hematology Keri Brophy-Martinez Unit 23: CHRONIC MYELOPROLIFERATIVE DISORDERS (MPD)
Myeloproliferative Disorders (MPD) concepts Neoplastic (clonal) disorders of hemopoietic stem cells Over-production of all cell lines, with usually one.
About these slides SPEC – Short Presentation in Emerging Concepts
Good morning… My presentation is about Calreticulin and PMF
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Myeloproliferative Neoplasms: A Contemporary Review.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Adenomatous ductal proliferation of the salivary gland
Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled.
Cellular origin of lymphoma
MYELOPROLIFERATIVE DISEASES
Kidney Involvement in Leukemia and Lymphoma
Diagnostic algorithm for suspected primary myelofibrosis
Diagnostic algorithm for suspected essential thrombocythemia
Julia Geyer and Attilio Orazi
Primary cutaneous mucinous carcinoma of the breast
RBC disorders 5 Ahmad Mansour, MD.
Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma  Jennifer L. Herrmann, Naveed Sami 
Volume 142, Issue 3, Pages (September 2012)
Volume 60, Pages (September 2017)
Transfusion Independency and Histological Remission in a Patient with Advanced Primary Myelofibrosis Receiving Iron-Chelation Therapy with Deferasirox.
Triple-Negative Breast Cancer
Chronic Leukemia Kristine Krafts, M.D..
Volume 7, Issue 5, Pages (May 2015)
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera.
Volume 1, Issue 4, Pages (July 2015)
Edwin A. McElroy, M.D., Robert L. Phyliky, M.D., Chin-Yang Li, M.D. 
Volume 4, Issue 4, Pages (May 2018)
Volume 61, Issue 6, Pages (June 2002)
Ujjawal H. Gandhi, William Senapedis, Erkan Baloglu, Thaddeus J
Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia  Fabrice Usseglio, Nathalie Beaufils, Anne Calleja, Sophie.
Quiz Page March 2008 American Journal of Kidney Diseases
Squamous Cell Carcinoma in the Ovary of a 14-Year-Old Year-Old Girl
Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab  Elizabeth Elliott, Salman Waheed, Sahr.
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics  Vincent T. Ma, Philip S. Boonstra,
Kidney Involvement in Leukemia and Lymphoma
Prefibrotisk Myelofibros
Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab  Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD 
Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I  Ruben A. Mesa, Srdan Verstovsek,
Volume 72, Issue 6, Pages (September 2007)
Quiz Page June 2008 American Journal of Kidney Diseases
Cytokine Expression Pattern in Bone Marrow Microenvironment after Allogeneic Stem Cell Transplantation in Primary Myelofibrosis  Kais Hussein, Angelika.
Papulolinear collagenoma
Gadolinium and nephrogenic systemic fibrosis
A Rare Case of Two Different Types of Cardiac Tumors in a Patient
Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature 
Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors  Geoffrey B. Johnson, MD, PhD, Marie Christine Aubry,
Volume 3, Issue 4, Pages (July 2017)
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera.
Meningioma Metastatic to the Lung
Volume 45, Issue 4, Pages (April 1964)
Clinicopathologic Analysis of POEMS Syndrome and Related Diseases
The neuropathology of brain metastases
Practical Measures of Clinical Benefit With Ruxolitinib Therapy: An Exploratory Analysis of COMFORT-I  Carole B. Miller, Rami S. Komrokji, Ruben A. Mesa,
Ayalew Tefferi, Pierre Noel, Curtis A. Hanson 
Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma  Jennifer L. Herrmann, Naveed Sami 
Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Advanced acral melanoma
Biclonal Non-small Cell Lung Cancer in Disseminated Tumor Cells and Tissue  Anna Puggina, MSc, Verena Kümmerlen, MD, Korinna Jöhrens-Leder, MD, Ulrich.
Pure Erythroid Leukemia Presenting in a HIV-Positive Patient
My Treatment Approach to Hairy Cell Leukemia
Volume 3, Issue 4, Pages (July 2017)
Quiz Page Answers May 2006 American Journal of Kidney Diseases
Quiz Page January 2010 American Journal of Kidney Diseases
Acute Megakaryocytic Leukemia
GERARDO COLON-OTERO, M.D.  Mayo Clinic Proceedings 
by Elisa Rumi, and Mario Cazzola
Ruxolitinib for Myelofibrosis–An Update of Its Clinical Effects
Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis  Alfonso Fiorelli, MD, PhD, Marina Accardo, MD, Emanuele Carelli,
Histopathology of SGAT
Presentation transcript:

Impact of Bone Marrow Pathology on the Clinical Management of Philadelphia Chromosome–Negative Myeloproliferative Neoplasms  Olga Pozdnyakova, Robert P. Hasserjian, Srdan Verstovsek, Attilio Orazi  Clinical Lymphoma, Myeloma and Leukemia  Volume 15, Issue 5, Pages 253-261 (May 2015) DOI: 10.1016/j.clml.2014.11.002 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Bone Marrow Histomorphology in ET (A), PMF (B), and PV (C). (A) Essential Thrombocythemia (ET): Normocellular Marrow With an Increased Number of Megakaryocytes and Loose Clusters of Large Hyperlobulated Megakaryocytes With Preserved Nuclear-to-Cytoplasmic Ratio That Lack Cytologic Atypia. (B) Primary Myelofibrosis (PMF): Hypercellular Bone Marrow Due to Increased Granulopoiesis. Megakaryocytes Form Tight Clusters and Show Cytologic Atypia With Abnormally Lobulated, Often Hyperchromatic Nuclei. The “Streaming” of Cells Is a Sign of Underlying Marrow Fibrosis. (C) Polycythemia Vera (PV): Hypercellular Bone Marrow Due to Panmyelosis. Unlike in PMF, Megakaryocytic Proliferation and Tight Cluster Formation Are Not Prominent Features in PV. Original Magnification, × 400, Hematoxylin and Eosin Stain Clinical Lymphoma, Myeloma and Leukemia 2015 15, 253-261DOI: (10.1016/j.clml.2014.11.002) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Bone Marrow Histology in Advanced Stages of Philadelphia Chromosome–Negative Myeloproliferative Neoplasms. (A) Primary Myelofibrosis, (B) Post–essential Thrombocythemia Myelofibrosis, and (C) Post–polycythemia Vera Myelofibrosis Show Similar Morphology With Hematopoietic Elements Embedded Into Fibrotic Stroma Surrounding or Associated With Clusters of Bizarre Megakaryocytes. Original Magnification, × 400, Hematoxylin and Eosin Stain Clinical Lymphoma, Myeloma and Leukemia 2015 15, 253-261DOI: (10.1016/j.clml.2014.11.002) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Bone Marrow Fibrosis Grading Based on World Health Organization Criteria. (A) MF-0: Fine Reticulin Meshworks Without Intersections. (B) MF-1: Diffuse Loose Reticulin Meshwork With Many Intersections in Perivascular Areas. (C) MF-2: Diffuse Dense Reticulin Meshwork With Extensive Intersections. (D) MF-3: Similar to MF-2 but With the Presence of Coarse Bundles of Thick Fibers, Consistent With Overt Collagen Deposition Apparent as Reduplication and “Tram-Track” Arrangement of the Fibers. Original Magnification, × 400 Reticulin Stain Abbreviation: MF = myelofibrosis. Clinical Lymphoma, Myeloma and Leukemia 2015 15, 253-261DOI: (10.1016/j.clml.2014.11.002) Copyright © 2015 The Authors Terms and Conditions